Inhibition of lipopolysaccharide-induced nitric oxide synthesis by nicotine through S6K1-p42/44 MAPK pathway and STAT3 (Ser 727) phosphorylation in Raw 264.7 cells

Cytokine

Volumn 44, Issue 1, 2008, Pages 126-134

  Park, Shin Young ^a   Baik, Yong Hae ^b   Cho, Ju Hwan ^a   Kim, Sung ^c   Lee, Ki Sung ^d   Han, Joong Soo ^a,d  

^a Hanyang University   (South Korea)

^b Dongguk University Ilsan Hospital   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d PaiChai University   (South Korea)

Author keywords

Lipopolysaccharide; Nicotine; Nitric oxide; S6K1; STAT3

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINE; NITRIC OXIDE; S6 KINASE; SMALL INTERFERING RNA; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYNTHESIS;

ANIMALS; CELL LINE; ENZYME ACTIVATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NICOTINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION;

EID: 52949104386     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.07.006     Document Type: Article

References (42)

1. Korhonen R., Lahti A., Kankaanranta H., and Moilanen E. Nitric oxide production and signaling in inflammation. Curr Drug Targets Inflamm Allergy 4 (2005) 471-479
2. Moncada S. Nitric oxide: discovery and impact on clinical medicine. J R Soc Med 92 (1999) 164-169
3. Marletta M.A. Nitric oxide synthase: aspects concerning structure and catalysis. Cell 78 (1994) 927-930
4. Alderton W.K., Cooper C.E., and Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem J 357 (2001) 593-615
5. Yoon S.W., Goh S.H., Chun J.S., Cho E.W., Lee M.K., Kim K.L., et al. alpha-Melanocyte-stimulating hormone inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production in leukocytes by modulating protein kinase A, p38 kinase, and nuclear factor kappa B signaling pathways. J Biol Chem 278 (2003) 32914-32920
6. Guha M., and Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 13 (2001) 85-94
7. Hawiger J. Innate immunity and inflammation: a transcriptional paradigm. Immunol Res 23 (2001) 99-109
8. Speranza L., De Lutiis M.A., Shaik Y.B., Felaco M., Patruno A., Tete A., et al. Localization and activity of iNOS in normal human lung tissue and lung cancer tissue. Int J Biol Markers 22 (2007) 226-231
9. Brennan P.A., Dennis S., Poller D., Quintero M., Puxeddu R., and Thomas G.J. Inducible nitric oxide synthase: correlation with extracapsular spread and enhancement of tumor cell invasion in head and neck squamous cell carcinoma. Head Neck 30 (2008) 208-214
10. Paruch S., El-Benna J., Djerdjouri B., Marullo S., and Perianin A. A role of p44/42 mitogen-activated protein kinases in formyl-peptide receptor-mediated phospholipase D activity and oxidant production. FASEB J 20 (2006) 142-144
11. Viinikainen A., Nyman T., Fyhrquist F., and Saijonmaa O. Downregulation of angiotensin converting enzyme by TNF-alpha in differentiating human macrophages. Cytokine 18 (2002) 304-310
12. Wittmann M., Kienlin P., Mommert S., Kapp A., and Werfel T. Suppression of IL-12 production by soluble CD40 ligand: evidence for involvement of the p44/42 mitogen-activated protein kinase pathway. J Immunol 168 (2002) 3793-3800
13. Galdiero M., Vitiello M., D'Isanto M., Raieta K., and Galdiero E. STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6. Cytokine 36 (2006) 218-228
14. Xuan Y.T., Guo Y., Zhu Y., Wang O.L., Rokosh G., and Bolli R. Endothelial nitric oxide synthase plays an obligatory role in the late phase of ischemic preconditioning by activating the protein kinase C epsilon p44/42 mitogen-activated protein kinase pSer-signal transducers and activators of transcription1/3 pathway. Circulation 116 (2007) 535-544
15. Dennis P.B., Fumagalli S., and Thomas G. Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation. Curr Opin Genet Dev 9 (1999) 49-54
16. Fingar D.C., and Blenis J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23 (2004) 3151-3171
17. Boyer D., Quintanilla R., and Lee-Fruman K.K. Regulation of catalytic activity of S6 kinase 2 during cell cycle. Mol Cell Biochem 307 (2008) 59-64
18. Brown E.J., Beal P.A., Keith C.T., Chen J., Shin T.B., and Schreiber S.L. Control of p70 s6 kinase by kinase activity of FRAP in vivo. Nature 377 (1995) 441-446
19. Sekulic A., Hudson C.C., Homme J.L., Yin P., Otterness D.M., Karnitz L.M., et al. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res 60 (2000) 3504-3513
20. Chen J. Novel regulatory mechanisms of mTOR signaling. Curr Top Microbiol Immunol 279 (2004) 245-257
21. Lim H.K., Choi Y.A., Park W., Lee T., Ryu S.H., Kim S.Y., et al. Phosphatidic acid regulates systemic inflammatory responses by modulating the Akt-mammalian target of rapamycin-p70 S6 kinase 1 pathway. J Biol Chem 278 (2003) 45117-45127
22. Yoshikawa H., Kurokawa M., Ozaki N., Nara K., Atou K., Takada E., et al. Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7. Clin Exp Immunol 146 (2006) 116-123
23. Dowling O., Rochelson B., Way K., Al-Abed Y., and Metz C.N. Nicotine inhibits cytokine production by placenta cells via NFkappaB: potential role in pregnancy-induced hypertension. Mol Med 13 (2007) 576-583
24. Shytle R.D., Mori T., Townsend K., Vendrame M., Sun N., Zeng J., et al. Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem 89 (2004) 337-343
25. Sugano N., Shimada K., Ito K., and Murai S. Nicotine inhibits the production of inflammatory mediators in U937 cells through modulation of nuclear factor-kappaB activation. Biochem Biophys Res Commun 252 (1998) 25-28
26. Sasagawa S., Suzuki K., Sakatani T., and Fujikura T. Effects of nicotine on the functions of human polymorphonuclear leukocytes in vitro. J Leukoc Biol 37 (1985) 493-502
27. Pabst M.J., Pabst K.M., Collier J.A., Coleman T.C., Lemons-Prince M.L., Godat M.S., et al. Inhibition of neutrophil and monocyte defensive functions by nicotine. J Periodontol 66 (1995) 1047-1055
28. Madretsma G.S., Donze G.J., van Dijk A.P., Tak C.J., Wilson J.H., and Zijlstra F.J. Nicotine inhibits the in vitro production of interleukin 2 and tumour necrosis factor-alpha by human mononuclear cells. Immunopharmacology 35 (1996) 47-51
29. Blanco A., Habib A., Levy-Toledano S., and Maclouf J. Involvement of tyrosine kinases in the induction of cyclo-oxygenase-2 in human endothelial cells. Biochem J 312 Pt. 2 (1995) 419-423
30. Chen C.C., Wang J.K., and Lin S.B. Antisense oligonucleotides targeting protein kinase C-alpha, -beta I, or -delta but not -eta inhibit lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: involvement of a nuclear factor kappa B-dependent mechanism. J Immunol 161 (1998) 6206-6214
31. Monick M.M., Carter A.B., Gudmundsson G., Mallampalli R., Powers L.S., and Hunninghake G.W. A phosphatidylcholine-specific phospholipase C regulates activation of p42/44 mitogen-activated protein kinases in lipopolysaccharide-stimulated human alveolar macrophages. J Immunol 162 (1999) 3005-3012
32. Zhang F., Zhao G., and Dong Z. Phosphatidylcholine-specific phospholipase C and D in stimulation of RAW264.7 mouse macrophage-like cells by lipopolysaccharide. Int Immunopharmacol 1 (2001) 1375-1384
33. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405 (2000) 458-462
34. Shin-young P., Koh Y.J., Cho J.H., Oh D.Y., Shin S.A., Lee K.S., et al. Nicotine inhibits bFGF-induced neurite outgrowth through suppression of NO synthesis in H19-7 cells. Neurochem Res 32 (2007) 481-488
35. De Simone R., Ajmone-Cat M.A., Carnevale D., and Minghetti L. Activation of alpha7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures. J Neuroinflammation 2 (2005) 4
36. Chang L., and Karin M. Mammalian MAP kinase signalling cascades. Nature 410 (2001) 37-40
37. Kim J.H., Kim J.E., Liu H.Y., Cao W., and Chen J. Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway. J Biol Chem 283 (2008) 708-715
38. Scott M.J., Godshall C.J., and Cheadle W.G. Jaks, STATs, cytokines, and sepsis. Clin Diagn Lab Immunol 9 (2002) 1153-1159
39. Wen Z., Zhong Z., and Darnell Jr. J.E. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82 (1995) 241-250
40. Yokogami K., Wakisaka S., Avruch J., and Reeves S.A. Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr Biol 10 (2000) 47-50
41. Stumhofer J.S., Silver J.S., Laurence A., Porrett P.M., Harris T.H., Turka L.A., et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 8 (2007) 1363-1371
42. de Jonge W.J., van der Zanden E.P., The F.O., Bijlsma M.F., van Westerloo D.J., Bennink R.J., et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 6 (2005) 844-851